$ILNS featuring Antisenilin for Alzheimer's

New Post Public Reply Private Reply Replies (0) Message Board
The Pit Bull

$ILNS featuring Antisenilin for Alzheimer's disease

This pioneering approach has gained considerable momentum over the past few years, and leading experts in the field have expressed optimism that drugs being developed using the company's proprietary patented technology herald an exciting new era of drug development for safe and effective disease-modifying treatments for Alzheimer's disease 1 . The company has granted two worldwide non-exclusive licenses to major pharmaceutical companies with products in Phase II and Phase III clinical under Intellect’s ANTISENILIN® patents and patent applications. In addition, the Company is developing its own follow-on generation product, which it believes will be the best-in-class.


Antisenilin Technology – How It Works

The brain is surrounded by and suspended in a liquid cushion called cerebrospinal fluid, which carries nutrients and essential chemicals to and debris away from the brain by a process known as “Bulk Flow”.

Under healthy conditions, flow of cerebrospinal fluid keeps nutrients and toxic metabolites balanced. However, in some older people, flow is reduced so that toxins that are normally carried away accumulate instead. Chief among these toxins is a protein called beta amyloid. (“A-beta” for short). A-beta is the brain cell toxin responsible for Alzheimer’s disease. A-beta is produced from a larger, normal brain protein called the Amyloid Precursor Protein, “APP for short”. APP is a critically important molecule present at the intersections where communications between nerve cells occur. APP is broken down when it is snipped by two cutting enzymes producing A-beta. In some cases, A-beta accumulates because it is over-produced, as is the case in early-onset cases of Alzheimer’s.

A-beta is first formed as a soluble single small molecule. These single forms of A-beta have a tendency to stick together and form clumps of increasing size as more A-beta sticks. These small aggregates attack the cell surface and cause oxidative damage. Eventually, the small clumps accumulate into large clumps, know as plaques. This progressive increase in aggregation results in additional harm to the brain, as white blood cells and antibodies from the immune system attack the clumps in a futile attempt to destroy them. Inflammation is the result of this immune attack, and inflammation causes additional damage to the brain.

Tangles are another microscopic form of toxic molecules. Tangles form inside the nerve cells and lead to further damage. The combination of A-beta toxicity outside the brain cell and tangles inside over time results in irreversible damage to brain cells, loss of connections between nerve cells and cell death. The first area in the brain to show this Alzheimer’s pathology is the hippocampus – the memory maker of the brain. The clinical result is loss of memory, and is followed by loss of other brain functions such as the ability to learn, communicate with language, and behave appropriately.

Dr. Chain’s approach consists of a safe way to remove A-beta protein, ensuring that the normal function of the important APP molecule is not affected. Given almost any substance, it is possible to create very specific antibodies called monoclonal antibodies. A monoclonal antibody will bind to the substance it was created against and will not bind normal molecules. Dr. Chain’s approach pinpoints unique molecular signatures at either end of A-beta which are not present in APP. ANTISENILIN antibodies only bind these molecular signatures, thus safely helping to shuttle A- beta away from sites of damage in the brain while leaving APP untouched and thus able to function normally. These free-end specific antibodies can also be made to bind aggregated forms of A?, including oligomers, and amyloid plaques.

Figure 1: ANTISENILIN ® antibodies target either end of A?

Bapineuzumab, which binds to the free amino (NH 2 ) terminus of Aß, is being tested in Phase III Clinical Trials by Janssen, a subsidiary of Johnson & Johnson and Wyeth/Pfizer.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 87

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 26

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 183

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 123

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 54

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 85

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading
Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 54

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 31

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 68

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 229

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading

Top 5 Most Recently Viewed Articles

Desreta Jackson's New Show: A Journey of Healing and Legacy

Updated Category News Views 551

Desreta Jackson Unveils Groundbreaking Show This Fall Desreta Jackson, who captivated audiences through her memorable role as young Celie in Steven Spielberg's acclaimed film The Color Purple, is set to make her return to the limelight with the launch of The Desreta Jackson Show this fall. Produced by Desicon Pictures, the show seeks to ignite meaningful conversations...

Continue Reading
Clarios Unveils Ambitious Initiative to Transform U.S. Manufacturing

Updated Category News Views 354

Clarios Set to Revolutionize U.S. Manufacturing Landscape Clarios is embarking on an exciting journey to bolster American manufacturing, with plans to establish a cutting-edge technology campus focusing on advanced supercapacitor systems production. This initiative is part of a comprehensive $6 billion investment strategy aimed at strengthening domestic supply chains....

Continue Reading
Franchise Equity Partners Expands with Strategic Valvoline Deal

Updated Category News Views 274

Franchise Equity Partners Forms Strategic Partnership with Valvoline Franchise Equity Partners (FEP) is thrilled to announce a new strategic partnership with Valvoline Inc. This collaboration marks a significant milestone as FEP plans to acquire 38 Valvoline company-owned stores. The stores, located in various regions of Texas, will be transitioning to a newly established...

Continue Reading
New Found Gold Announces Successful Financing Round Closing

Updated Category News Views 183

Recent Financing Success of New Found Gold New Found Gold Corp. (TSXV: NFG) (NYSE-A: NFGC) is excited to share the successful closing of its second and final tranche in the bought deal financing, securing a remarkable C$63 million to advance its projects. This milestone marks a significant achievement for the Company, facilitating crucial developments in the exploration...

Continue Reading
Joby Aviation Surpasses Expectations in Q3 Financials

Updated Category News Views 194

Joby Aviation's Remarkable Growth in Q3 Joby Aviation, Inc. (NYSE: JOBY) has recently experienced a substantial surge in stock value, reflecting investor confidence following the release of its third-quarter earnings report. This report highlighted significant movements, particularly as it beat estimates on revenue, even though it faced a mixed assessment regarding its...

Continue Reading